Business
Syqe Enters Into Distribution Agreement With TerrAscend to Bring Revolutionary Medical Cannabis Treatment to Canada
Syqe Enters Into Distribution Agreement With TerrAscend to Bring Revolutionary Medical Can...
About this update from Terrascend Corp.
[{"type":"text","content":"\n\n\n\nSyqe Enters Into Distribution Agreement With TerrAscend to Bring Revolutionary Medical Cannabis Treatment to Canada\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTEL AVIV, Israel and TORONTO, Sept. 16, 2019\n\n\n\nLeading pharma-tech company inks deal with TerrAscend to bring the first and only inhalation device that can deliver safe, precise and consistent dosages of medical cannabis to the Canadian market\n TEL AVIV, Israel and TORONTO, Sept. 16, 2019 /CNW/ -- Today, Syqe Medical, Ltd. and TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) announced an exclusive distribution agreement to bring Syqe's flagship product, the Syqe™ Inhaler, to the Canadian market. Backed by rigorous clinical trials, the Syqe Inhaler is the world's first metered-dose medical cannabis inhaler to provide predictable, precise and consistent treatment at pharmaceutical standards. Syqe first debuted its product to the Israeli market in June 2019, and through TerrAscend is bringing its breakthrough technology to the Canadian market to ease the suffering of patients dealing with chronic conditions.\n\"Syqe's goal since inception has been to bring relief to as many patients as possible in the fastest possible way, and we spent eight years developing the Syqe Inhaler to ensure that when introduced, it would make a significant positive impact on patients' lives,\" says Perry Davidson, Syqe CEO and Founder. \"We have been searching for a partner that is truly focused on the medical side of cannabis. We are thrilled to be working with TerrAscend to share our groundbreaking technology with a progressive market at the forefront of medical cannabis treatment.\"\nTerrAscend, through its wholly owned subsidiaries TerrAscend Canada and Solace Health Network, will lead marketing, distribution and sales efforts across Canada. Through Solace Health's patient-centric online platform and medical coverage assistance, as well as its wide network of medical professionals, TerrAscend is uniquely positioned for success with the Syqe treatment in the Canadian medical cannabis ...